Company
Vibalogics is a partner for companies committed to developing therapeutic and prophylactic vaccines and biologics. Our company is a one-stop-shop for virus manufacturing, bacterial manufacturing, quality control, formulating, filling, and lyophilization. Whenever required we work in full compliance with international GMP standards in a BSL2-classified state-of-the-art facility.

 

Products produced by Vibalogics are predominantly used for prophylactic vaccination, therapeutic vaccination, gene therapy or virotherapy using oncolytic viruses.

 

 

 

Vibalogics places the greatest value on being a reliable partner and offering high-quality services. Our company distinguishes itself by being highly flexible, establishing and maintaining open communication lines and making our partners' aims our own.

 

Vibalogics takes pleasure in inviting you to study the following pages for additional information. Feel free to contact our team directly who will be happy to assist you.


Schedule of Events:

- Phacilitate Vaccine Forum, Singapore, September 19 - 21, 2011

- World Vaccine Manufacturing Congress, Lyon, France, October 10 - 13, 2011

- Bio Europe, Düsseldorf, Germany, October 31 - November 2, 2011

- Phacilitate Vaccine Forum, Washington DC, USA, January 30 - February 1, 2012

- Perspectives of Cell- and Gene-based Medicines, Frankfurt/Main, Germany, March 15 - 17, 2012

- ISPE EU Aseptic Conference, Frankfurt/Main, Germany, March 26 - 27, 2012 

- World Gene Therapy Congress Europe, London, United Kingdom, May 21 - 23, 2012

- BIO International Convention, Boston, USA, June 18 - 21, 2012